Researchers from the University of Leicester and Leicester's Hospitals have announced a breakthrough advance in the results of the world-first clinical trial with actual patients of a new drug to treat particular blood cancers.
Nov 11, 2015
0
1272
A few years ago, Javier Benítez, director of the Human Genetics Group at the CNIO, received a call from Pablo García Pavía, from the Cardiology Unit of the Puerta de Hierro University Hospital. This cardiologist was treating ...
Sep 25, 2015
0
103
Monash researchers have uncovered the mechanism used by a common type of blood cancer to hide itself from the immune system.
Aug 11, 2015
0
42
The genetic variability of a tumour could be a predictor for its aggressiveness: the greater the variability in gene expression, the more aggressive the tumour is likely to be. This is the hypothesis that the CNIO Structural ...
Feb 5, 2015
1
9
Idelalisib (trade name Zydelig) has been available since September 2014 for patients with follicular lymphoma or chronic lymphocytic leukaemia (CLL). The German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Jan 8, 2015
0
3
(Medical Xpress)—Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia.
Jul 9, 2014
0
0
A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months.
Apr 23, 2014
0
0
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...
Mar 19, 2014
0
0
A transformational new treatment for multiple sclerosis (MS) - the result of over three decades of research in Cambridge - was approved today by the EU agency responsible for regulating new drugs.
Sep 18, 2013
0
0
Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.
Jun 13, 2013
0
0
